Keri Wyllie

Keri Wyllie has a diverse work experience. Keri currently holds the position of Director of Preclinical Operations at Codagenix Inc. since January 2024. Prior to that, they served as the Associate Director of Translational Biology at the same company from May 2022 to January 2024. Keri also worked as the Biosafety Officer and Laboratory Manager at Codagenix Inc. from June 2020 to May 2022.

In addition to their industry experience, Keri Wyllie has academic experience as well. Keri worked as an Adjunct Professor at LIU Post, where they taught undergraduate microbiology laboratory courses and created curriculum materials to enhance students' understanding of medical microbiology. Keri also served as the Laboratory Manager at LIU Post from January 2011 to May 2020 and as a Laboratory Assistant from September 2005 to January 2011.

Furthermore, Keri Wyllie worked as a Thesis Researcher at C.W. Post Campus/Nassau County Medical Examiner's Office from September 2007 to April 2009. Their research focused on designing and validating a qPCR reaction to detect meningitis-causing genes in specific bacteria.

Overall, Keri Wyllie's work experience demonstrates a strong background in laboratory management, translational biology, and academic instruction in the field of microbiology.

Keri Wyllie holds a Bachelor of Science degree in Forensic Science from LIU Post, which they obtained from 2005 to 2009. Keri furthered their education at LIU Post, earning a Master of Public Administration degree in Health Care Administration from 2011 to 2014. Additionally, they have obtained certifications in Shipping Infectious Substances and Related Materials from Saf-T-Pak Inc. in August 2022, Adult First Aid/CPR/AED from the American Red Cross in July 2022, and RCRA/DOT Hazmat Transportation from Lion Technology Inc. in October 2018.